| 12.07 -0.71 (-5.56%) | 01-30 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 17.52 |
1-year : | 19.78 |
| Resists | First : | 15 |
Second : | 16.94 |
| Pivot price | 13.65 |
|||
| Supports | First : | 11.86 |
Second : | 9.87 |
| MAs | MA(5) : | 13.11 |
MA(20) : | 14.22 |
| MA(100) : | 11.35 |
MA(250) : | 8.03 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 9.4 |
D(3) : | 17.3 |
| RSI | RSI(14): 36.3 |
|||
| 52-week | High : | 16.94 | Low : | 2.75 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ OWLT ] has closed above bottom band by 1.9%. Bollinger Bands are 9.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 12.49 - 12.56 | 12.56 - 12.62 |
| Low: | 11.7 - 11.79 | 11.79 - 11.86 |
| Close: | 11.94 - 12.09 | 12.09 - 12.19 |
Owlet, Inc. operates as a digital parenting platform in the United States. The company's platform focuses on giving real-time data and insights to parents. Its products include Smart Sock, a baby monitor to track an infant's oxygen levels, heart rates, and sleep trends; Dream Sock, an app to assist children for better sleep; Cam, a video streaming app to hear and see baby from anywhere; and Dream Lab, an interactive online platform that assists families in building healthy sleep habits. The company also offers Dream Duo, a monitoring system for baby's sleeping habits and includes wearable sock monitor, HD video, and digital sleep coach. Owlet, Inc. was founded in 2012 and is based in Lehi, Utah.
Fri, 30 Jan 2026
Owlet Strengthens Healthcare Partnerships: Can Adoption Scale? - The Globe and Mail
Fri, 30 Jan 2026
Owlet Strengthens Healthcare Partnerships: Can Adoption Scale? - Zacks Investment Research
Thu, 29 Jan 2026
Owlet vs. Masimo: Which Medical Monitoring Stock Is the Better Buy? - TradingView
Thu, 22 Jan 2026
Owlet (NYSE:OWLT) CEO Jonathan Harris Sells 2,311 Shares - MarketBeat
Wed, 21 Jan 2026
What 900 million hours of baby sleep reveal about the first year - Stock Titan
Wed, 14 Jan 2026
Owlet (OWLT) Price Target Increased by 14.29% to 17.34 - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 28 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 5.3 (%) |
| Held by Institutions | 53.4 (%) |
| Shares Short | 565 (K) |
| Shares Short P.Month | 441 (K) |
| EPS | -2.81 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -3.28 |
| Profit Margin | -39.7 % |
| Operating Margin | 3.7 % |
| Return on Assets (ttm) | -10.3 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 44.5 % |
| Gross Profit (p.s.) | 1.88 |
| Sales Per Share | 3.61 |
| EBITDA (p.s.) | -0.39 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -4.3 |
| PEG Ratio | 0 |
| Price to Book value | -3.68 |
| Price to Sales | 3.34 |
| Price to Cash Flow | -45.42 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |